Novo Nordisk A/S
Largo
Actualizado

$NVO expected have better second half (H2)

1 087
- Potential Inverse H&S on daily?
- In the worst case, NVO goes to 200 monthly moving average around $36
- Nonetheless, We are bottoming fundamentally only question is how fast the turn around gonna be.
Nota
- I had a very big position starting this year and but sold pre-earning when they unprofessionally released earnings on breakeven.

- I have bought back around 43.xx but not gonna build a massive position this time because I am afraid that turn around might be slower.
Nota
- There are blood in the streets so I want to build bigger position in other companies where turn around could be faster. However, I am buying NVO for long term as weightloss and well being is multi year secular trend
Nota
- NVO will still have better second half where it recovers.
- However, it's clear LLY is a superior drug and NVO latest results confirm it
Operación cerrada: precio stop alcanzado
Nota
pre-market $42 ; I believe this is heading to 200 day monthly moving average around $36 and then might find support or bottom based on fundamentals
Nota
pre-market $42 ; I believe this is heading to 200 day monthly moving average around $36 and then might find support or bottom based on fundamentals
Nota
NVO as I mentioned probably has bottomed around 200 day monthly average around 35-36 bucks

Exención de responsabilidad

La información y las publicaciones no constituyen, ni deben considerarse como, asesoramiento o recomendaciones financieras, de inversión, de trading u otro tipo, proporcionadas o respaldadas por TradingView. Obtenga más información en Condiciones de uso.